开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2211498, encodeId=78ec2211498b8, content=请问这个杂志Under Editorial Consideration后现在成了Under Review，是外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=Dr Young, createdTime=Mon Jun 24 22:57:12 CST 2024, time=2024-06-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157901, encodeId=bb1e215e90112, content=投稿命中率:5.0 经验分享：感觉cancer cell， cancer discovery和nature cancer 未来会形成三足鼎立之势。 目前来看cancer cell还是当仁不让的老大哥。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3f92397506, createdName=shyhihihi, createdTime=Fri Sep 15 21:54:13 CST 2023, time=2023-09-15, status=1, ipAttribution=宾夕法尼亚), GetPortalCommentsPageByObjectIdResponse(id=1224062, encodeId=18cf1224062e4, content=顶刊啊！把它排在cancer cell 之前了。希望下半年完成工作，投搞试一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:17:00 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2155633, encodeId=dc2f2155633aa, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：医学 经验分享：更偏重临床，不能说不好，但是相比之下，文章质量和Cancer Cell有差距。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krgITEeMQ2icKV217mmNAw5IbUf9IZhxfJ4qIfOo59YMibg9n6KuicjX6wFCibesxO8bpOtCb4DsFbp41/0, createdBy=1a8e2047779, createdName=ms9508293866653270, createdTime=Fri Sep 01 18:26:42 CST 2023, time=2023-09-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1005346, encodeId=1224100534683, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：血液领域，投了一篇，1周拒稿，原因是既往这个领域已发表了一些文献，还是创新性差了一些，但是推荐改投AACR旗下新创期刊Blood Cancer Discovery，文章质量也是顶级，但是目前没有IF，还是放弃改投了。总之，如果创新性有所欠缺几乎没有希望。杂志的排版真是漂亮，文章首页精美。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f9e1689535, createdName=千寻1076, createdTime=Thu Aug 05 13:07:11 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104774, encodeId=09dd1104e7417, content=撰写文章题目有没有技巧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104773, encodeId=234e1104e73a9, content=文章题目怎么写更好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558822, encodeId=a3ae55882233, content=这个杂志关注很久了.所发的文章水平质量都确实高.一般人发不了.要想发得确实有好的idea.详细的机制研究sunliang 2018-06-30 00:00:00 发表: 的确是很经典的杂志, beContent=sunliang 2018-06-30 00:00:00 发表: 的确是很经典的杂志, objectType=tool_impact_factor, channel=null, level=null, likeNumber=467, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Tue Jul 03 00:00:00 CST 2018, time=2018-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558675, encodeId=3bc85586e5e0, content=的确是很经典的杂志bigapple001 2018-05-18 22:36:00 发表: 特别喜欢这个杂志的排版这个杂志基本上都收热点的文章冷门研究很难发上去, beContent=bigapple001 2018-05-18 22:36:00 发表: 特别喜欢这个杂志的排版这个杂志基本上都收热点的文章冷门研究很难发上去, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Jun 30 00:00:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556199, encodeId=1915556199d6, content=特别喜欢这个杂志的排版这个杂志基本上都收热点的文章冷门研究很难发上去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=502, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Fri May 18 22:36:00 CST 2018, time=2018-05-18, status=1, ipAttribution=)]

2024-06-24 Dr Young 来自北京

请问这个杂志Under Editorial Consideration后现在成了Under Review，是外审了吗

61 0

[GetPortalCommentsPageByObjectIdResponse(id=2211498, encodeId=78ec2211498b8, content=请问这个杂志Under Editorial Consideration后现在成了Under Review，是外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=Dr Young, createdTime=Mon Jun 24 22:57:12 CST 2024, time=2024-06-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157901, encodeId=bb1e215e90112, content=投稿命中率:5.0 经验分享：感觉cancer cell， cancer discovery和nature cancer 未来会形成三足鼎立之势。 目前来看cancer cell还是当仁不让的老大哥。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3f92397506, createdName=shyhihihi, createdTime=Fri Sep 15 21:54:13 CST 2023, time=2023-09-15, status=1, ipAttribution=宾夕法尼亚), GetPortalCommentsPageByObjectIdResponse(id=1224062, encodeId=18cf1224062e4, content=顶刊啊！把它排在cancer cell 之前了。希望下半年完成工作，投搞试一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:17:00 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2155633, encodeId=dc2f2155633aa, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：医学 经验分享：更偏重临床，不能说不好，但是相比之下，文章质量和Cancer Cell有差距。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krgITEeMQ2icKV217mmNAw5IbUf9IZhxfJ4qIfOo59YMibg9n6KuicjX6wFCibesxO8bpOtCb4DsFbp41/0, createdBy=1a8e2047779, createdName=ms9508293866653270, createdTime=Fri Sep 01 18:26:42 CST 2023, time=2023-09-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1005346, encodeId=1224100534683, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：血液领域，投了一篇，1周拒稿，原因是既往这个领域已发表了一些文献，还是创新性差了一些，但是推荐改投AACR旗下新创期刊Blood Cancer Discovery，文章质量也是顶级，但是目前没有IF，还是放弃改投了。总之，如果创新性有所欠缺几乎没有希望。杂志的排版真是漂亮，文章首页精美。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f9e1689535, createdName=千寻1076, createdTime=Thu Aug 05 13:07:11 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104774, encodeId=09dd1104e7417, content=撰写文章题目有没有技巧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104773, encodeId=234e1104e73a9, content=文章题目怎么写更好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558822, encodeId=a3ae55882233, content=这个杂志关注很久了.所发的文章水平质量都确实高.一般人发不了.要想发得确实有好的idea.详细的机制研究sunliang 2018-06-30 00:00:00 发表: 的确是很经典的杂志, beContent=sunliang 2018-06-30 00:00:00 发表: 的确是很经典的杂志, objectType=tool_impact_factor, channel=null, level=null, likeNumber=467, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Tue Jul 03 00:00:00 CST 2018, time=2018-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558675, encodeId=3bc85586e5e0, content=的确是很经典的杂志bigapple001 2018-05-18 22:36:00 发表: 特别喜欢这个杂志的排版这个杂志基本上都收热点的文章冷门研究很难发上去, beContent=bigapple001 2018-05-18 22:36:00 发表: 特别喜欢这个杂志的排版这个杂志基本上都收热点的文章冷门研究很难发上去, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Jun 30 00:00:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556199, encodeId=1915556199d6, content=特别喜欢这个杂志的排版这个杂志基本上都收热点的文章冷门研究很难发上去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=502, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Fri May 18 22:36:00 CST 2018, time=2018-05-18, status=1, ipAttribution=)]

2023-09-15 shyhihihi 来自宾夕法尼亚

投稿命中率:5.0
经验分享：感觉cancer cell， cancer discovery和nature cancer 未来会形成三足鼎立之势。
目前来看cancer cell还是当仁不让的老大哥。

109 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2211498, encodeId=78ec2211498b8, content=请问这个杂志Under Editorial Consideration后现在成了Under Review，是外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=Dr Young, createdTime=Mon Jun 24 22:57:12 CST 2024, time=2024-06-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157901, encodeId=bb1e215e90112, content=投稿命中率:5.0 经验分享：感觉cancer cell， cancer discovery和nature cancer 未来会形成三足鼎立之势。 目前来看cancer cell还是当仁不让的老大哥。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3f92397506, createdName=shyhihihi, createdTime=Fri Sep 15 21:54:13 CST 2023, time=2023-09-15, status=1, ipAttribution=宾夕法尼亚), GetPortalCommentsPageByObjectIdResponse(id=1224062, encodeId=18cf1224062e4, content=顶刊啊！把它排在cancer cell 之前了。希望下半年完成工作，投搞试一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:17:00 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2155633, encodeId=dc2f2155633aa, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：医学 经验分享：更偏重临床，不能说不好，但是相比之下，文章质量和Cancer Cell有差距。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krgITEeMQ2icKV217mmNAw5IbUf9IZhxfJ4qIfOo59YMibg9n6KuicjX6wFCibesxO8bpOtCb4DsFbp41/0, createdBy=1a8e2047779, createdName=ms9508293866653270, createdTime=Fri Sep 01 18:26:42 CST 2023, time=2023-09-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1005346, encodeId=1224100534683, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：血液领域，投了一篇，1周拒稿，原因是既往这个领域已发表了一些文献，还是创新性差了一些，但是推荐改投AACR旗下新创期刊Blood Cancer Discovery，文章质量也是顶级，但是目前没有IF，还是放弃改投了。总之，如果创新性有所欠缺几乎没有希望。杂志的排版真是漂亮，文章首页精美。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f9e1689535, createdName=千寻1076, createdTime=Thu Aug 05 13:07:11 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104774, encodeId=09dd1104e7417, content=撰写文章题目有没有技巧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104773, encodeId=234e1104e73a9, content=文章题目怎么写更好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558822, encodeId=a3ae55882233, content=这个杂志关注很久了.所发的文章水平质量都确实高.一般人发不了.要想发得确实有好的idea.详细的机制研究sunliang 2018-06-30 00:00:00 发表: 的确是很经典的杂志, beContent=sunliang 2018-06-30 00:00:00 发表: 的确是很经典的杂志, objectType=tool_impact_factor, channel=null, level=null, likeNumber=467, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Tue Jul 03 00:00:00 CST 2018, time=2018-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558675, encodeId=3bc85586e5e0, content=的确是很经典的杂志bigapple001 2018-05-18 22:36:00 发表: 特别喜欢这个杂志的排版这个杂志基本上都收热点的文章冷门研究很难发上去, beContent=bigapple001 2018-05-18 22:36:00 发表: 特别喜欢这个杂志的排版这个杂志基本上都收热点的文章冷门研究很难发上去, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Jun 30 00:00:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556199, encodeId=1915556199d6, content=特别喜欢这个杂志的排版这个杂志基本上都收热点的文章冷门研究很难发上去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=502, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Fri May 18 22:36:00 CST 2018, time=2018-05-18, status=1, ipAttribution=)]

2022-06-02 cindichaw

顶刊啊！把它排在cancer cell 之前了。希望下半年完成工作，投搞试一下。

211 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2211498, encodeId=78ec2211498b8, content=请问这个杂志Under Editorial Consideration后现在成了Under Review，是外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=Dr Young, createdTime=Mon Jun 24 22:57:12 CST 2024, time=2024-06-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157901, encodeId=bb1e215e90112, content=投稿命中率:5.0 经验分享：感觉cancer cell， cancer discovery和nature cancer 未来会形成三足鼎立之势。 目前来看cancer cell还是当仁不让的老大哥。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3f92397506, createdName=shyhihihi, createdTime=Fri Sep 15 21:54:13 CST 2023, time=2023-09-15, status=1, ipAttribution=宾夕法尼亚), GetPortalCommentsPageByObjectIdResponse(id=1224062, encodeId=18cf1224062e4, content=顶刊啊！把它排在cancer cell 之前了。希望下半年完成工作，投搞试一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:17:00 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2155633, encodeId=dc2f2155633aa, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：医学 经验分享：更偏重临床，不能说不好，但是相比之下，文章质量和Cancer Cell有差距。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krgITEeMQ2icKV217mmNAw5IbUf9IZhxfJ4qIfOo59YMibg9n6KuicjX6wFCibesxO8bpOtCb4DsFbp41/0, createdBy=1a8e2047779, createdName=ms9508293866653270, createdTime=Fri Sep 01 18:26:42 CST 2023, time=2023-09-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1005346, encodeId=1224100534683, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：血液领域，投了一篇，1周拒稿，原因是既往这个领域已发表了一些文献，还是创新性差了一些，但是推荐改投AACR旗下新创期刊Blood Cancer Discovery，文章质量也是顶级，但是目前没有IF，还是放弃改投了。总之，如果创新性有所欠缺几乎没有希望。杂志的排版真是漂亮，文章首页精美。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f9e1689535, createdName=千寻1076, createdTime=Thu Aug 05 13:07:11 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104774, encodeId=09dd1104e7417, content=撰写文章题目有没有技巧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104773, encodeId=234e1104e73a9, content=文章题目怎么写更好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558822, encodeId=a3ae55882233, content=这个杂志关注很久了.所发的文章水平质量都确实高.一般人发不了.要想发得确实有好的idea.详细的机制研究sunliang 2018-06-30 00:00:00 发表: 的确是很经典的杂志, beContent=sunliang 2018-06-30 00:00:00 发表: 的确是很经典的杂志, objectType=tool_impact_factor, channel=null, level=null, likeNumber=467, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Tue Jul 03 00:00:00 CST 2018, time=2018-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558675, encodeId=3bc85586e5e0, content=的确是很经典的杂志bigapple001 2018-05-18 22:36:00 发表: 特别喜欢这个杂志的排版这个杂志基本上都收热点的文章冷门研究很难发上去, beContent=bigapple001 2018-05-18 22:36:00 发表: 特别喜欢这个杂志的排版这个杂志基本上都收热点的文章冷门研究很难发上去, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Jun 30 00:00:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556199, encodeId=1915556199d6, content=特别喜欢这个杂志的排版这个杂志基本上都收热点的文章冷门研究很难发上去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=502, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Fri May 18 22:36:00 CST 2018, time=2018-05-18, status=1, ipAttribution=)]

2023-09-01 ms9508293866653270 来自陕西省

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：医学
经验分享：更偏重临床，不能说不好，但是相比之下，文章质量和Cancer Cell有差距。

141 0

[GetPortalCommentsPageByObjectIdResponse(id=2211498, encodeId=78ec2211498b8, content=请问这个杂志Under Editorial Consideration后现在成了Under Review，是外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=Dr Young, createdTime=Mon Jun 24 22:57:12 CST 2024, time=2024-06-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157901, encodeId=bb1e215e90112, content=投稿命中率:5.0 经验分享：感觉cancer cell， cancer discovery和nature cancer 未来会形成三足鼎立之势。 目前来看cancer cell还是当仁不让的老大哥。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3f92397506, createdName=shyhihihi, createdTime=Fri Sep 15 21:54:13 CST 2023, time=2023-09-15, status=1, ipAttribution=宾夕法尼亚), GetPortalCommentsPageByObjectIdResponse(id=1224062, encodeId=18cf1224062e4, content=顶刊啊！把它排在cancer cell 之前了。希望下半年完成工作，投搞试一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:17:00 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2155633, encodeId=dc2f2155633aa, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：医学 经验分享：更偏重临床，不能说不好，但是相比之下，文章质量和Cancer Cell有差距。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krgITEeMQ2icKV217mmNAw5IbUf9IZhxfJ4qIfOo59YMibg9n6KuicjX6wFCibesxO8bpOtCb4DsFbp41/0, createdBy=1a8e2047779, createdName=ms9508293866653270, createdTime=Fri Sep 01 18:26:42 CST 2023, time=2023-09-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1005346, encodeId=1224100534683, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：血液领域，投了一篇，1周拒稿，原因是既往这个领域已发表了一些文献，还是创新性差了一些，但是推荐改投AACR旗下新创期刊Blood Cancer Discovery，文章质量也是顶级，但是目前没有IF，还是放弃改投了。总之，如果创新性有所欠缺几乎没有希望。杂志的排版真是漂亮，文章首页精美。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f9e1689535, createdName=千寻1076, createdTime=Thu Aug 05 13:07:11 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104774, encodeId=09dd1104e7417, content=撰写文章题目有没有技巧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104773, encodeId=234e1104e73a9, content=文章题目怎么写更好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558822, encodeId=a3ae55882233, content=这个杂志关注很久了.所发的文章水平质量都确实高.一般人发不了.要想发得确实有好的idea.详细的机制研究sunliang 2018-06-30 00:00:00 发表: 的确是很经典的杂志, beContent=sunliang 2018-06-30 00:00:00 发表: 的确是很经典的杂志, objectType=tool_impact_factor, channel=null, level=null, likeNumber=467, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Tue Jul 03 00:00:00 CST 2018, time=2018-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558675, encodeId=3bc85586e5e0, content=的确是很经典的杂志bigapple001 2018-05-18 22:36:00 发表: 特别喜欢这个杂志的排版这个杂志基本上都收热点的文章冷门研究很难发上去, beContent=bigapple001 2018-05-18 22:36:00 发表: 特别喜欢这个杂志的排版这个杂志基本上都收热点的文章冷门研究很难发上去, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Jun 30 00:00:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556199, encodeId=1915556199d6, content=特别喜欢这个杂志的排版这个杂志基本上都收热点的文章冷门研究很难发上去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=502, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Fri May 18 22:36:00 CST 2018, time=2018-05-18, status=1, ipAttribution=)]

2021-08-05 千寻1076

审稿速度:1.0 | 投稿命中率:5.0
经验分享：血液领域，投了一篇，1周拒稿，原因是既往这个领域已发表了一些文献，还是创新性差了一些，但是推荐改投AACR旗下新创期刊Blood Cancer Discovery，文章质量也是顶级，但是目前没有IF，还是放弃改投了。总之，如果创新性有所欠缺几乎没有希望。杂志的排版真是漂亮，文章首页精美。

3 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2211498, encodeId=78ec2211498b8, content=请问这个杂志Under Editorial Consideration后现在成了Under Review，是外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=Dr Young, createdTime=Mon Jun 24 22:57:12 CST 2024, time=2024-06-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157901, encodeId=bb1e215e90112, content=投稿命中率:5.0 经验分享：感觉cancer cell， cancer discovery和nature cancer 未来会形成三足鼎立之势。 目前来看cancer cell还是当仁不让的老大哥。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3f92397506, createdName=shyhihihi, createdTime=Fri Sep 15 21:54:13 CST 2023, time=2023-09-15, status=1, ipAttribution=宾夕法尼亚), GetPortalCommentsPageByObjectIdResponse(id=1224062, encodeId=18cf1224062e4, content=顶刊啊！把它排在cancer cell 之前了。希望下半年完成工作，投搞试一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:17:00 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2155633, encodeId=dc2f2155633aa, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：医学 经验分享：更偏重临床，不能说不好，但是相比之下，文章质量和Cancer Cell有差距。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krgITEeMQ2icKV217mmNAw5IbUf9IZhxfJ4qIfOo59YMibg9n6KuicjX6wFCibesxO8bpOtCb4DsFbp41/0, createdBy=1a8e2047779, createdName=ms9508293866653270, createdTime=Fri Sep 01 18:26:42 CST 2023, time=2023-09-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1005346, encodeId=1224100534683, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：血液领域，投了一篇，1周拒稿，原因是既往这个领域已发表了一些文献，还是创新性差了一些，但是推荐改投AACR旗下新创期刊Blood Cancer Discovery，文章质量也是顶级，但是目前没有IF，还是放弃改投了。总之，如果创新性有所欠缺几乎没有希望。杂志的排版真是漂亮，文章首页精美。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f9e1689535, createdName=千寻1076, createdTime=Thu Aug 05 13:07:11 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104774, encodeId=09dd1104e7417, content=撰写文章题目有没有技巧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104773, encodeId=234e1104e73a9, content=文章题目怎么写更好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558822, encodeId=a3ae55882233, content=这个杂志关注很久了.所发的文章水平质量都确实高.一般人发不了.要想发得确实有好的idea.详细的机制研究sunliang 2018-06-30 00:00:00 发表: 的确是很经典的杂志, beContent=sunliang 2018-06-30 00:00:00 发表: 的确是很经典的杂志, objectType=tool_impact_factor, channel=null, level=null, likeNumber=467, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Tue Jul 03 00:00:00 CST 2018, time=2018-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558675, encodeId=3bc85586e5e0, content=的确是很经典的杂志bigapple001 2018-05-18 22:36:00 发表: 特别喜欢这个杂志的排版这个杂志基本上都收热点的文章冷门研究很难发上去, beContent=bigapple001 2018-05-18 22:36:00 发表: 特别喜欢这个杂志的排版这个杂志基本上都收热点的文章冷门研究很难发上去, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Jun 30 00:00:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556199, encodeId=1915556199d6, content=特别喜欢这个杂志的排版这个杂志基本上都收热点的文章冷门研究很难发上去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=502, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Fri May 18 22:36:00 CST 2018, time=2018-05-18, status=1, ipAttribution=)]

2021-12-29 衣谷

撰写文章题目有没有技巧？

233 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2211498, encodeId=78ec2211498b8, content=请问这个杂志Under Editorial Consideration后现在成了Under Review，是外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=Dr Young, createdTime=Mon Jun 24 22:57:12 CST 2024, time=2024-06-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157901, encodeId=bb1e215e90112, content=投稿命中率:5.0 经验分享：感觉cancer cell， cancer discovery和nature cancer 未来会形成三足鼎立之势。 目前来看cancer cell还是当仁不让的老大哥。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3f92397506, createdName=shyhihihi, createdTime=Fri Sep 15 21:54:13 CST 2023, time=2023-09-15, status=1, ipAttribution=宾夕法尼亚), GetPortalCommentsPageByObjectIdResponse(id=1224062, encodeId=18cf1224062e4, content=顶刊啊！把它排在cancer cell 之前了。希望下半年完成工作，投搞试一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:17:00 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2155633, encodeId=dc2f2155633aa, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：医学 经验分享：更偏重临床，不能说不好，但是相比之下，文章质量和Cancer Cell有差距。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krgITEeMQ2icKV217mmNAw5IbUf9IZhxfJ4qIfOo59YMibg9n6KuicjX6wFCibesxO8bpOtCb4DsFbp41/0, createdBy=1a8e2047779, createdName=ms9508293866653270, createdTime=Fri Sep 01 18:26:42 CST 2023, time=2023-09-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1005346, encodeId=1224100534683, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：血液领域，投了一篇，1周拒稿，原因是既往这个领域已发表了一些文献，还是创新性差了一些，但是推荐改投AACR旗下新创期刊Blood Cancer Discovery，文章质量也是顶级，但是目前没有IF，还是放弃改投了。总之，如果创新性有所欠缺几乎没有希望。杂志的排版真是漂亮，文章首页精美。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f9e1689535, createdName=千寻1076, createdTime=Thu Aug 05 13:07:11 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104774, encodeId=09dd1104e7417, content=撰写文章题目有没有技巧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104773, encodeId=234e1104e73a9, content=文章题目怎么写更好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558822, encodeId=a3ae55882233, content=这个杂志关注很久了.所发的文章水平质量都确实高.一般人发不了.要想发得确实有好的idea.详细的机制研究sunliang 2018-06-30 00:00:00 发表: 的确是很经典的杂志, beContent=sunliang 2018-06-30 00:00:00 发表: 的确是很经典的杂志, objectType=tool_impact_factor, channel=null, level=null, likeNumber=467, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Tue Jul 03 00:00:00 CST 2018, time=2018-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558675, encodeId=3bc85586e5e0, content=的确是很经典的杂志bigapple001 2018-05-18 22:36:00 发表: 特别喜欢这个杂志的排版这个杂志基本上都收热点的文章冷门研究很难发上去, beContent=bigapple001 2018-05-18 22:36:00 发表: 特别喜欢这个杂志的排版这个杂志基本上都收热点的文章冷门研究很难发上去, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Jun 30 00:00:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556199, encodeId=1915556199d6, content=特别喜欢这个杂志的排版这个杂志基本上都收热点的文章冷门研究很难发上去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=502, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Fri May 18 22:36:00 CST 2018, time=2018-05-18, status=1, ipAttribution=)]

2021-12-28 桑晒麦拉

文章题目怎么写更好？

257 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2211498, encodeId=78ec2211498b8, content=请问这个杂志Under Editorial Consideration后现在成了Under Review，是外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=Dr Young, createdTime=Mon Jun 24 22:57:12 CST 2024, time=2024-06-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157901, encodeId=bb1e215e90112, content=投稿命中率:5.0 经验分享：感觉cancer cell， cancer discovery和nature cancer 未来会形成三足鼎立之势。 目前来看cancer cell还是当仁不让的老大哥。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3f92397506, createdName=shyhihihi, createdTime=Fri Sep 15 21:54:13 CST 2023, time=2023-09-15, status=1, ipAttribution=宾夕法尼亚), GetPortalCommentsPageByObjectIdResponse(id=1224062, encodeId=18cf1224062e4, content=顶刊啊！把它排在cancer cell 之前了。希望下半年完成工作，投搞试一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:17:00 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2155633, encodeId=dc2f2155633aa, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：医学 经验分享：更偏重临床，不能说不好，但是相比之下，文章质量和Cancer Cell有差距。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krgITEeMQ2icKV217mmNAw5IbUf9IZhxfJ4qIfOo59YMibg9n6KuicjX6wFCibesxO8bpOtCb4DsFbp41/0, createdBy=1a8e2047779, createdName=ms9508293866653270, createdTime=Fri Sep 01 18:26:42 CST 2023, time=2023-09-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1005346, encodeId=1224100534683, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：血液领域，投了一篇，1周拒稿，原因是既往这个领域已发表了一些文献，还是创新性差了一些，但是推荐改投AACR旗下新创期刊Blood Cancer Discovery，文章质量也是顶级，但是目前没有IF，还是放弃改投了。总之，如果创新性有所欠缺几乎没有希望。杂志的排版真是漂亮，文章首页精美。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f9e1689535, createdName=千寻1076, createdTime=Thu Aug 05 13:07:11 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104774, encodeId=09dd1104e7417, content=撰写文章题目有没有技巧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104773, encodeId=234e1104e73a9, content=文章题目怎么写更好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558822, encodeId=a3ae55882233, content=这个杂志关注很久了.所发的文章水平质量都确实高.一般人发不了.要想发得确实有好的idea.详细的机制研究sunliang 2018-06-30 00:00:00 发表: 的确是很经典的杂志, beContent=sunliang 2018-06-30 00:00:00 发表: 的确是很经典的杂志, objectType=tool_impact_factor, channel=null, level=null, likeNumber=467, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Tue Jul 03 00:00:00 CST 2018, time=2018-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558675, encodeId=3bc85586e5e0, content=的确是很经典的杂志bigapple001 2018-05-18 22:36:00 发表: 特别喜欢这个杂志的排版这个杂志基本上都收热点的文章冷门研究很难发上去, beContent=bigapple001 2018-05-18 22:36:00 发表: 特别喜欢这个杂志的排版这个杂志基本上都收热点的文章冷门研究很难发上去, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Jun 30 00:00:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556199, encodeId=1915556199d6, content=特别喜欢这个杂志的排版这个杂志基本上都收热点的文章冷门研究很难发上去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=502, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Fri May 18 22:36:00 CST 2018, time=2018-05-18, status=1, ipAttribution=)]

2018-07-03 sunliang

这个杂志关注很久了.所发的文章水平质量都确实高.一般人发不了.要想发得确实有好的idea.详细的机制研究sunliang 2018-06-30 00:00:00 发表:
的确是很经典的杂志

sunliang 2018-06-30 00:00:00 发表: 的确是很经典的杂志

467 0

[GetPortalCommentsPageByObjectIdResponse(id=2211498, encodeId=78ec2211498b8, content=请问这个杂志Under Editorial Consideration后现在成了Under Review，是外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=Dr Young, createdTime=Mon Jun 24 22:57:12 CST 2024, time=2024-06-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157901, encodeId=bb1e215e90112, content=投稿命中率:5.0 经验分享：感觉cancer cell， cancer discovery和nature cancer 未来会形成三足鼎立之势。 目前来看cancer cell还是当仁不让的老大哥。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3f92397506, createdName=shyhihihi, createdTime=Fri Sep 15 21:54:13 CST 2023, time=2023-09-15, status=1, ipAttribution=宾夕法尼亚), GetPortalCommentsPageByObjectIdResponse(id=1224062, encodeId=18cf1224062e4, content=顶刊啊！把它排在cancer cell 之前了。希望下半年完成工作，投搞试一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:17:00 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2155633, encodeId=dc2f2155633aa, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：医学 经验分享：更偏重临床，不能说不好，但是相比之下，文章质量和Cancer Cell有差距。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krgITEeMQ2icKV217mmNAw5IbUf9IZhxfJ4qIfOo59YMibg9n6KuicjX6wFCibesxO8bpOtCb4DsFbp41/0, createdBy=1a8e2047779, createdName=ms9508293866653270, createdTime=Fri Sep 01 18:26:42 CST 2023, time=2023-09-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1005346, encodeId=1224100534683, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：血液领域，投了一篇，1周拒稿，原因是既往这个领域已发表了一些文献，还是创新性差了一些，但是推荐改投AACR旗下新创期刊Blood Cancer Discovery，文章质量也是顶级，但是目前没有IF，还是放弃改投了。总之，如果创新性有所欠缺几乎没有希望。杂志的排版真是漂亮，文章首页精美。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f9e1689535, createdName=千寻1076, createdTime=Thu Aug 05 13:07:11 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104774, encodeId=09dd1104e7417, content=撰写文章题目有没有技巧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104773, encodeId=234e1104e73a9, content=文章题目怎么写更好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558822, encodeId=a3ae55882233, content=这个杂志关注很久了.所发的文章水平质量都确实高.一般人发不了.要想发得确实有好的idea.详细的机制研究sunliang 2018-06-30 00:00:00 发表: 的确是很经典的杂志, beContent=sunliang 2018-06-30 00:00:00 发表: 的确是很经典的杂志, objectType=tool_impact_factor, channel=null, level=null, likeNumber=467, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Tue Jul 03 00:00:00 CST 2018, time=2018-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558675, encodeId=3bc85586e5e0, content=的确是很经典的杂志bigapple001 2018-05-18 22:36:00 发表: 特别喜欢这个杂志的排版这个杂志基本上都收热点的文章冷门研究很难发上去, beContent=bigapple001 2018-05-18 22:36:00 发表: 特别喜欢这个杂志的排版这个杂志基本上都收热点的文章冷门研究很难发上去, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Jun 30 00:00:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556199, encodeId=1915556199d6, content=特别喜欢这个杂志的排版这个杂志基本上都收热点的文章冷门研究很难发上去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=502, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Fri May 18 22:36:00 CST 2018, time=2018-05-18, status=1, ipAttribution=)]

2018-06-30 sunliang

的确是很经典的杂志bigapple001 2018-05-18 22:36:00 发表:
特别喜欢这个杂志的排版这个杂志基本上都收热点的文章冷门研究很难发上去

bigapple001 2018-05-18 22:36:00 发表: 特别喜欢这个杂志的排版这个杂志基本上都收热点的文章冷门研究很难发上去

468 0

[GetPortalCommentsPageByObjectIdResponse(id=2211498, encodeId=78ec2211498b8, content=请问这个杂志Under Editorial Consideration后现在成了Under Review，是外审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=Dr Young, createdTime=Mon Jun 24 22:57:12 CST 2024, time=2024-06-24, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2157901, encodeId=bb1e215e90112, content=投稿命中率:5.0 经验分享：感觉cancer cell， cancer discovery和nature cancer 未来会形成三足鼎立之势。 目前来看cancer cell还是当仁不让的老大哥。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3f92397506, createdName=shyhihihi, createdTime=Fri Sep 15 21:54:13 CST 2023, time=2023-09-15, status=1, ipAttribution=宾夕法尼亚), GetPortalCommentsPageByObjectIdResponse(id=1224062, encodeId=18cf1224062e4, content=顶刊啊！把它排在cancer cell 之前了。希望下半年完成工作，投搞试一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:17:00 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2155633, encodeId=dc2f2155633aa, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：医学 经验分享：更偏重临床，不能说不好，但是相比之下，文章质量和Cancer Cell有差距。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krgITEeMQ2icKV217mmNAw5IbUf9IZhxfJ4qIfOo59YMibg9n6KuicjX6wFCibesxO8bpOtCb4DsFbp41/0, createdBy=1a8e2047779, createdName=ms9508293866653270, createdTime=Fri Sep 01 18:26:42 CST 2023, time=2023-09-01, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1005346, encodeId=1224100534683, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：血液领域，投了一篇，1周拒稿，原因是既往这个领域已发表了一些文献，还是创新性差了一些，但是推荐改投AACR旗下新创期刊Blood Cancer Discovery，文章质量也是顶级，但是目前没有IF，还是放弃改投了。总之，如果创新性有所欠缺几乎没有希望。杂志的排版真是漂亮，文章首页精美。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0f9e1689535, createdName=千寻1076, createdTime=Thu Aug 05 13:07:11 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104774, encodeId=09dd1104e7417, content=撰写文章题目有没有技巧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104773, encodeId=234e1104e73a9, content=文章题目怎么写更好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558822, encodeId=a3ae55882233, content=这个杂志关注很久了.所发的文章水平质量都确实高.一般人发不了.要想发得确实有好的idea.详细的机制研究sunliang 2018-06-30 00:00:00 发表: 的确是很经典的杂志, beContent=sunliang 2018-06-30 00:00:00 发表: 的确是很经典的杂志, objectType=tool_impact_factor, channel=null, level=null, likeNumber=467, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Tue Jul 03 00:00:00 CST 2018, time=2018-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558675, encodeId=3bc85586e5e0, content=的确是很经典的杂志bigapple001 2018-05-18 22:36:00 发表: 特别喜欢这个杂志的排版这个杂志基本上都收热点的文章冷门研究很难发上去, beContent=bigapple001 2018-05-18 22:36:00 发表: 特别喜欢这个杂志的排版这个杂志基本上都收热点的文章冷门研究很难发上去, objectType=tool_impact_factor, channel=null, level=null, likeNumber=468, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sat Jun 30 00:00:00 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=556199, encodeId=1915556199d6, content=特别喜欢这个杂志的排版这个杂志基本上都收热点的文章冷门研究很难发上去, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=502, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Fri May 18 22:36:00 CST 2018, time=2018-05-18, status=1, ipAttribution=)]

2018-05-18 bigapple001

特别喜欢这个杂志的排版这个杂志基本上都收热点的文章冷门研究很难发上去

502 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务